Global Bio pharma Buffer Market Is Expected To Grow At A CAGR of 7.2% From 2020 to 2027

Biopharma buffers are used to resist change in the pH and ionic concentration of biochemical process under clinical investigation, buffers basically comprise of acid and base conjugates. Henderson-Hasselbalch equation is critical in determining the pH of the buffer solutions such as acetates, phosphates, carbonates, organic buffers, etc.

Advertisements

Phosphate buffers are presently dominating the type segment for the biopharma buffer market on account of increasing demand from the life science industry and academic research institutes. The major factors responsible for its huge popularity among researchers is its pH, osmolarity, and ionic concentration similar to the human bodily fluids. It is used as the diluent, rinse containers containing cells, reference spectrum to measure protein adsorption on ellipsometry. Acetate buffers are widely employed in molecular biology especially in the purification and precipitation of nucleic acids. Organic buffers will be showcasing magnificent market growth on account of increasing demand for novel drug development such as vaccines, immunotherapy, biologics, etc.

Browse the full report Bio Pharma Buffer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/bio-pharma-buffer-market

The biopharmaceutical industry is currently leading the end-user segment for the biopharma buffer market. Significant rise in the spread of virulent diseases such as ebola, COVID-19, swine flu, etc. creates the burgeoning requirement for the development of vaccines and novel drugs to prevent the spread and reduce the mortality rate associate with the viral infections. Academia and research institutes worldwide are keen to register rampant market growth owing to the strategic collaboration between pharmaceutical companies to promote breakthrough research and technology to serve mankind. Huge monetary funds provided by governmental healthcare agencies to establish academic research institutes.

North America is currently representing the largest market share in the geography segment for biopharma buffer market. The key attributes associated with its market dominance are proactive role adopted by healthcare agencies to promote research and development activities for the treatment of infectious and lifestyle disorders in the region. The existence of well-developed healthcare infrastructure and constantly growing biopharmaceutical segments together drive the biopharma buffer market in the region. Europe is in the 2nd position in the regional market for the biopharma buffer market. Increasing demand for the discovery of novel vaccines and immunotherapy to treat infectious and autoimmune disease further propel the biopharma buffer market growth in the region. The Asia Pacific is anticipated to register comfortable market growth during the forecast period on account of developing healthcare infrastructure and flourishing drug formulation and development market.

Biopharmaceutical companies actively engaged in the manufacturing of biopharma buffer are Merck KGaA.,Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Lonza, Becton Dickinson and Company, Promega Corporation, GE Healthcare, ANGUS Chemical Company, Takara Bio, Inc., and VWR International, LLC.

Market Key Takeaways:

Significant increase in the drug development activities across the life science industry

Rising prevalence of infectious disease creates a burgeoning requirement of novel drug discovery and vaccine development to curb its fatality

The constant rise in the academic research institutes worldwide to promote breakthrough research and technology to cater to the medical needs of mankind